| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7473653
[patent_doc_number] => 20040121940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Elongated and multiple spacers in activatible produgs'
[patent_app_type] => new
[patent_app_number] => 10/472921
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20744
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121940.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472921 | Elongated and multiple spacers in activatible prodrugs | Mar 24, 2002 | Issued |
Array
(
[id] => 5845429
[patent_doc_number] => 20020132835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Novel compositions'
[patent_app_type] => new
[patent_app_number] => 10/096258
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3566
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132835.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096258
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096258 | Compositions | Mar 12, 2002 | Issued |
Array
(
[id] => 5846059
[patent_doc_number] => 20020132973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Peptide parathyroid hormone analogs'
[patent_app_type] => new
[patent_app_number] => 10/097079
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44028
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132973.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097079 | Peptide parathyroid hormone analogs | Mar 12, 2002 | Abandoned |
Array
(
[id] => 7018782
[patent_doc_number] => 20050220801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Immunopotentiators'
[patent_app_type] => utility
[patent_app_number] => 10/471177
[patent_app_country] => US
[patent_app_date] => 2002-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6035
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471177 | Immunopotentiators | Mar 10, 2002 | Abandoned |
Array
(
[id] => 6438930
[patent_doc_number] => 20020128206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Somatostatin antagonists and agonists that act at the sst subtype 2 receptor'
[patent_app_type] => new
[patent_app_number] => 10/093239
[patent_app_country] => US
[patent_app_date] => 2002-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19002
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10093239
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/093239 | Somatostatin antagonists and agonists that act at the sst subtype 2 receptor | Mar 6, 2002 | Abandoned |
Array
(
[id] => 6674995
[patent_doc_number] => 20030060598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Glycopeptide derivatives and pharmaceutical compositions containing the same'
[patent_app_type] => new
[patent_app_number] => 10/092088
[patent_app_country] => US
[patent_app_date] => 2002-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30001
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060598.pdf
[firstpage_image] =>[orig_patent_app_number] => 10092088
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/092088 | Glycopeptide derivatives and pharmaceutical compositions containing the same | Mar 5, 2002 | Issued |
Array
(
[id] => 5923027
[patent_doc_number] => 20020115612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Poly (N-substituted glycines) with nucleotide base substituents'
[patent_app_type] => new
[patent_app_number] => 10/071577
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4283
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115612.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071577 | Poly (N-substituted glycines) with nucleotide base substituents | Feb 7, 2002 | Abandoned |
Array
(
[id] => 961205
[patent_doc_number] => 06951918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-04
[patent_title] => 'Peptidic procollagen C-proteinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/072730
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17534
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/951/06951918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10072730
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/072730 | Peptidic procollagen C-proteinase inhibitors | Feb 6, 2002 | Issued |
Array
(
[id] => 6622095
[patent_doc_number] => 20020065230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/054531
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22591
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065230.pdf
[firstpage_image] =>[orig_patent_app_number] => 10054531
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/054531 | Protease inhibitors | Jan 21, 2002 | Abandoned |
| 09/913810 | Di-and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin s | Jan 8, 2002 | Abandoned |
| 60/453710 | Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same | Jan 2, 2002 | Pending |
| 09/914881 | Method of treating hair loss using non-immunosuppressive compounds | Dec 27, 2001 | Abandoned |
Array
(
[id] => 6158794
[patent_doc_number] => 20020147150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Sustained-release preparation'
[patent_app_type] => new
[patent_app_number] => 10/025967
[patent_app_country] => US
[patent_app_date] => 2001-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15685
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147150.pdf
[firstpage_image] =>[orig_patent_app_number] => 10025967
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/025967 | Sustained-release preparation | Dec 25, 2001 | Abandoned |
Array
(
[id] => 993806
[patent_doc_number] => 06916905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-12
[patent_title] => 'Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/037358
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18985
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916905.pdf
[firstpage_image] =>[orig_patent_app_number] => 10037358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/037358 | Dmt-Tic di-and tri-peptidic derivatives and related compositions and methods of use | Dec 20, 2001 | Issued |
Array
(
[id] => 5908020
[patent_doc_number] => 20020142966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Inhibitors of the E2F-1/cyclin interaction for cancer therapy'
[patent_app_type] => new
[patent_app_number] => 10/024935
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8440
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142966.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024935 | Inhibitors of the E2F-1/cyclin interaction for cancer therapy | Dec 18, 2001 | Abandoned |
| 10/009720 | Pseudomycin amide and ester analogs | Dec 12, 2001 | Abandoned |
Array
(
[id] => 720521
[patent_doc_number] => 07049396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes'
[patent_app_type] => utility
[patent_app_number] => 10/014147
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 8446
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014147
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014147 | Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes | Dec 6, 2001 | Issued |
Array
(
[id] => 7467410
[patent_doc_number] => 20040053819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Chronic treatment regimen using glucagon-like insulinotropic peptides'
[patent_app_type] => new
[patent_app_number] => 10/450124
[patent_app_country] => US
[patent_app_date] => 2003-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17135
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053819.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450124 | Chronic treatment regimen using glucagon-like insulinotropic peptides | Dec 6, 2001 | Issued |
Array
(
[id] => 642186
[patent_doc_number] => 07122627
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-17
[patent_title] => 'Lactam inhibitors of Hepatitis C virus NS3 protease'
[patent_app_type] => utility
[patent_app_number] => 10/010184
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27360
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/122/07122627.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010184 | Lactam inhibitors of Hepatitis C virus NS3 protease | Dec 5, 2001 | Issued |
Array
(
[id] => 5923479
[patent_doc_number] => 20020115713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Inhibition of cell surface protein disulfide isomerase'
[patent_app_type] => new
[patent_app_number] => 10/002698
[patent_app_country] => US
[patent_app_date] => 2001-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7180
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115713.pdf
[firstpage_image] =>[orig_patent_app_number] => 10002698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/002698 | Inhibition of cell surface protein disulfide isomerase | Dec 4, 2001 | Issued |
